Always takes longer to close the year-end 4th quarter. Gotta make sure there is no junk on the asset side of the balance sheet, and make sure the earnings you report are bullet proof. This company has been diligent throughout its history maintaining a strong and clean balance sheet and I expect that to continue. Nice to see such support in the upper 8's. A base is forming from which to catapult next year. North American is nicely positioned in the niche nuclear medicine market, without debt and with a clear direction. I expect them to continue tremendous growth, continue product development and be seriously courted by some huge medical device/biotech in the upcoming years. Belong and prosper!